BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7690732)

  • 1. Initial characterization of an anti-CD5 monoclonal antibody obtained from leukemic cells infiltrating lymphocytes.
    Delfini C; Centis F; Muretto P; Staccioli MP; Pazzaglia C
    Haematologica; 1993; 78(3):145-50. PubMed ID: 7690732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a feline T-cell-specific monoclonal antibody reactive with a CD5-like molecule.
    Ackley CD; Cooper MD
    Am J Vet Res; 1992 Apr; 53(4):466-71. PubMed ID: 1375007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.
    Gramatzki M; Ludwig WD; Burger R; Moos P; Rohwer P; Grünert C; Sendler A; Kalden JR; Andreesen R; Henschke F; Moldenhauer G
    Exp Hematol; 1998 Dec; 26(13):1209-14. PubMed ID: 9845376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
    de Kroon JF; de Paus RA; Kluin-Nelemans HC; Kluin PM; van Bergen CA; Munro AJ; Hale G; Willemze R; Falkenburg JH
    Exp Hematol; 1996 Jul; 24(8):919-26. PubMed ID: 8690051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
    Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
    J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
    Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
    J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of human T cell proliferation by a monoclonal antibody to CD5.
    Spertini F; Stohl W; Ramesh N; Moody C; Geha RS
    J Immunol; 1991 Jan; 146(1):47-52. PubMed ID: 1701800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells.
    Ueda R; Nishida K; Koide Y; Tsuge I; Seto M; Yoshida M; Miyoshi I; Ota K; Takahashi T
    Cancer Res; 1985 Mar; 45(3):1314-9. PubMed ID: 2578877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-GD3 monoclonal antibody analysis of childhood T-cell acute lymphoblastic leukemia: detection of a target antigen for antibody-mediated cytolysis.
    Reaman GH; Taylor BJ; Merritt WD
    Cancer Res; 1990 Jan; 50(1):202-5. PubMed ID: 2403416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction of naive and memory BoCD4 lymphocytes in calves with a monoclonal antibody, CC76, to a restricted determinant of the bovine leukocyte-common antigen, CD45.
    Howard CJ; Sopp P; Parsons KR; McKeever DJ; Taracha EL; Jones BV; MacHugh ND; Morrison WI
    Eur J Immunol; 1991 Sep; 21(9):2219-26. PubMed ID: 1716214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
    Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
    Antin JH; Bierer BE; Smith BR; Guinan EC; Provost MM; Ferrara J; Macklis RM; Tarbell NJ; Blythman H; Bouloux C
    Prog Clin Biol Res; 1990; 333():207-15. PubMed ID: 1689852
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
    Fishwild DM; Aberle S; Bernhard SL; Kung AH
    Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.